The majority of nosocomial bloodstream infections are caused by opportunistic pathogens, many of which are part of the human microbial flora. These microorganisms take advantage of weaknesses in the host to shift from being harmless commensals to aggressive pathogens. Prominent examples include Enterobacter species, Pseudomonas aeruginosa, and Staphylococcus aureus.
Although bacteria are the predominant source of hospital-acquired infections, fungal infections continue to increase dramatically. Candida species are the agents responsible for almost 80% of nosocomial fungal infections and are the fourth-most-frequent cause of all such disseminated infections. Furthermore, the crude mortality associated with Candida bloodstream infections, or candidemia, is the highest of all bloodstream infections. Despite the emergence of other Candida species, C. albicans remains the leading cause of life-threatening, disseminated Candida infections.
Among the approximately 150 fungal species known to cause infections in humans, C. albicans is one of the rare fungi that are part of the normal human microflora, and is carried by about half the population. C. albicans does not grow in a single shape, but is polymorphic, with cells developing as spherical yeasts or filaments, including pseudohyphal and true hyphal forms. All morphological forms have been found in infected tissue; however, the hyphal cells are thought to be the more invasive cells penetrating tissue.
• Candida albicans, a fungus that is part of the microflora for about half the human population, causes nosocomial bloodstream infections and is the leading cause of life-threatening, disseminated Candida infections.
• When C. albicans cells enter the bloodstream, they adapt rapidly to this new environment by expressing a distinct set of genes, including those associated with oxidative stress, the glyoxylate cycle and hyphal formation.
• Transcript profiling shows that neutrophils dominate the host response to blood-borne C. albicans cells. 
Microarrays Being Used To Investigate C. albicans Infections
DNA microarrays provide a powerful means by which we can monitor expression levels of most genes during infections. We profiled C. albicans by inoculating cells into heparinized fresh human blood or plasma and incubating under semiaerobic conditions at 37°C. Cells were collected at regular intervals, mRNA isolated, and gene expression levels analyzed (Fig. 1) . When C. albicans cells enter the bloodstream, they encounter a new environment to which they adapt rapidly by expressing a distinct set of genes while down-regulating other genes. Despite the blood being a hostile environment, C. albicans cells remain physiologically active from the outset of their exposure to it. Within the first 10 minutes the cells up-regulate expression of the 12% of genes that encode components of the protein synthesis machinery, thus enabling the fungus to respond to other specific demands they encounter while exposed to blood.
After 30 minutes of being exposed to blood, 40% of Candida cells begin to produce germ tubes, the initial phase of hyphal growth. This morphologic shift is accompanied by accelerated expression of hyphal growth-associated genes, including the aspartic proteinase genes SAP4, SAP5, and SAP6. However, overall growth is significantly reduced for those cells in blood compared to those in plasma.
Many C. albicans cells associate with leukocytes as early as 10 minutes after being exposed to blood. At this time, the cells up-regulate genes associated with oxidative stress, the glyoxylate cycle, and, surprisingly, glycolysis. When phagocytic cells ingest microbes, the microbes presumably encounter a nutrient-poor environment, which is consistent with them inducing the glyoxylate cycle for growth in sugar-poor media and the oxidative burst of aggressive oxygencontaining molecules that results in oxidative stress. However, up-regulating both glycolysis and the glyoxylate cycle seems contradictory, leading us to suspect that we are detecting two populations of C. albicans cells: those that are phagocytosed and those that are not.
C. albicans Cells Respond Differently to Specific Blood Components
C. albicans cells respond to the soluble and cellular components of human blood. Soluble components of plasma contain numerous antimicrobial activities, including factors of the complement system that can directly kill microbes and iron-binding proteins such as transferrin that sequester this essential growth factor.
Many cellular components of blood, apart from the erythrocytes, have potent antimicro- bial activities. For example, the granulocytes, or polymorphonuclear leukocytes, are composed of neutrophils (50 -75% of leukocytes), eosinophils (1-5%), and basophils (0 -1%). Although both neutrophils and eosinophils can ingest microorganisms, neutrophils seem to be the principal means by which the innate immune system rapidly clears microbial pathogens. The monocytes (2-8% of leukocytes) are potential phagocytic cells that convert to macrophages in infected tissues. Lymphocytes (B and T cells) represent 20 -40% of the leukocytes and are key elements of cell-mediated and adaptive immunity.
We separated blood into four fractions consisting of plasma, red cells, mononuclear cells (lymphocytes and monocytes), and granulocytes (mainly neutrophils), resuspended the three cell fractions into plasma at the concentration they reach in whole blood, and then introduced C. albicans for 30 to 60 minutes before analysis by microscopy, cell viability tests, and transcriptional profiling.
More than 80% of the C. albicans cells that were exposed to plasma, red cells, or mononuclear cells produced germ tubes, whereas only 4% of the fungal cells exposed to neutrophils had germ tubes after 30 minutes. When we tested fungal cell viability, 56% of cells survived in whole blood for 60 minutes, more than 80% remained viable in the mononuclear cell fraction, 96% remained viable in the red cell fraction, and 100% remained viable in plasma. However, only 37% survived in the neutrophil fraction. Therefore, neutrophils, but not red cells, monocytes or lymphocytes, or plasma components, block growth and kill fungal cells in blood efficiently.
What accounts for more C. albicans cells surviving when exposed to whole blood than when exposed to neutrophils? Plasma is a strong inducer of hyphal formation, and cells immediately switch to this growth form when they contact plasma. Would it be an advantage for C. albicans to grow in the hyphal form in blood? Other studies indicated that factors secreted from hyphal cells inhibit killing by neutrophils; C. albicans cells phagocytosed by macrophages produce hyphae that penetrate membranes and kill macrophages; hyphal cells, but not yeast cells, induce phagocytosis by endothelial cells, perhaps enabling C. albicans to escape the bloodstream; hyphal cells may adhere more strongly than yeast cells to endothelial cells; and hyphal cells have invasive properties to assist in penetrating tissues surrounding blood vessels.
Thus, switching to hyphal growth may have advantages over the yeast form. However, it is not the hyphal morphology but its transcriptional program that likely accounts for hyphaeassociated pathogenesis. Despite their reduced virulence, even those cells that are locked in the yeast phase retain some ability to cross the endothelial barrier of blood vessels.
Granulocytes Govern C. albicans Transcriptional Response
The gene expression patterns of C. albicans cells exposed to whole blood or to neutrophils are similar (Fig. 2) . Thus, neutrophils apparently govern the transcriptional response of C. albicans in human blood, whereas the red cells, mononuclear cells, and plasma appear to have only a minor influence.
Gene expression profiles reflect the physiological condition of cells and the microenvironment to which they are exposed (Fig. 3) . For example, when cells are exposed to red cells, mononuclear cells, or plasma, the C. albicans genes associated with protein synthesis, glycolysis, and hyphal formation are up-regulated. In contrast, when cells were exposed to neutrophils, genes associated with detoxification of reactive oxygen species, the glyoxylate cycle, and amino acid metabolism are up-regulated in response to oxidative stress as well as carbohydrate and amino acid starvation. Thus, the transcript profile of C. albicans in blood reveals two populations of cells, some of which are in contact with neutrophils while the rest are not.
How do neutrophils arrest growth and induce oxidative stress? Phagocytosis may lead to antifungal components such as lactoferrin, elastase, defensins, and reactive oxygen species being released into the phagolysosome. Alternatively, these components may be secreted into the extracellular space. Although phagocytosis would seem to explain the starvation response, only 38% of C. albicans cells are phagocytosed. However, exposure to neutrophils strongly upregulates genes linked to oxidative stress, including genes encoding catalases and superoxide dismutases. These enzymes eliminate endogenous reactive oxygen species accidentally generated during respiration. In pathogenic microbes, they may have an additional function in detoxifying reactive oxygen species caused by the oxidative burst of phagocytic cells.
C. albicans contains as many as six genes encoding superoxide dismutases (SOD1-SOD6), three of which have C-terminal sequences that are typical for proteins attached to cell membranes or cell wall via structures. Why produce superoxide dismutases that face the extracellular space? Possibly these enzymes detoxify reactive oxygen species released by phagocytic cells that the fungal cells encounter. Our finding that the surface-associated Sod5 is induced when yeast cells contact or are phagocytosed by neutrophils supports this idea.
Lessons from Transcriptional Profiling of C. albicans in Blood
Our approach of exposing microbial pathogens to blood and blood fractions proves simple and highly reproducible, and thus could be used for any microorganisms that disseminate through the blood system. However, this system lacks some components, such as endothelial cells surrounding the bloodstream, that may partake in host responses to pathogenic microbes. For example, endothelial cells may act directly on C. albicans cells entering the blood or may attract granulocytes. Nonetheless, gene expression pat- terns in this system resemble those in cells isolated from infected animals.
Transcript profiling shows that neutrophils dominate the host response by confronting C. albicans cells with a hostile environment. To survive, the fungus induces genes involved in amino acid pathways, nitrogen metabolism, the glyoxylate cycle, and oxidative stress response.
Thus, microbes act as biosensors, and transcript profiling is a way to read their output. In this case, neutrophils are key to the host defense against invading C. albicans cells. However, the fungus induces a large number of genes to counteract the neutrophils, enabling this pathogen to survive in the bloodstream, even if only briefly, to cause life-threatening systemic infections.
